Lorlatinib/lorlatinib price in China

Lorlatinib/Lorlatinib is indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK) positive as measured by an FDA approved test. Lorlatinib was administered in201811Menstrual AmericaFDAapproved for marketing and will be launched in China in April 2022.

Lorlatinib/Lorlatinib Imported from China, the cost is relatively high, each box costs more than 2 more than 10,000. The cost of domestic imports is relatively high and ordinary families cannot afford it. At present, there are many regular pharmaceutical factories producing overseas. The manufacturers are different, the versions are different, and the prices are also different. However, the dosage and specifications of the pharmaceutical ingredients are the same, and the effects are similar. The retail price of Everest pharmaceutical manufacturers in Bangladesh100mg30tablets5000yuan, the retail price of pharmaceutical manufacturers in Laos and ASEAN100mg30tablets3The price of 100 mg 30 tablets of Laos Element Pharmaceuticals is around 1,078, and the retail price of Laos United Pharmaceuticals is 3about 1,078. Patients can choose drugs according to their own conditions.

Lorlatinib/The recommended dose of Lorlatinib is 100 mg orally, once daily. Patients with severe renal impairment: 75 mg orally once daily. The most common (incidence≥20%)adverse reactions and Grade 3-4 laboratory abnormalities with lorlatinib are edema, peripheral neuropathy, weight gain, cognitive effects, fatigue, dyspnea, arthralgia, diarrhea, mood effects, hypercholesterolemia, hypertriglyceridemia, and cough. If you want to get more high-quality information, you can contact yaode, yaoWe will do our best to help you learn more about high-quality overseas drugs.